ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice

Conclusions/interpretationThe RG54 peptide exhibits good prospects for providing glucose control and reducing the risk of cardiovascular disease in individuals with severe insulin resistance.

Source: Diabetologia - May 7, 2019 Category: Endocrinology Source Type: research